AIO0207(a)_3B | R Documentation |
Kaplan-Meier digitized data from AIO0207(a), figure 3B (PMID 26361971). A reported sample size of 472 for a primary endpoint of time_tx_failure in colorectal cancer.
`AIO0207(a)_3B`
A data frame of 301 observations and 3 variables:
time | event time (in months) | |
event | PFS event indicator (0 : no event, 1 : event) |
|
arm | treatment arms (5fu_bev, no_tx) | |
Hegewisch-Becker S, Graeven U, Lerchenmüller CA, et al. Maintenance strategies after first-line oxaliplatin plus fluoropyrimidine plus bevacizumab for patients with metastatic colorectal cancer (AIO 0207): a randomised, non-inferiority, open-label, phase 3 trial. Lancet Oncol 2015; 16: 1355–69.
summary(`AIO0207(a)_3B`)
kmplot(`AIO0207(a)_3B`)
Add the following code to your website.
For more information on customizing the embed code, read Embedding Snippets.